https://scholars.lib.ntu.edu.tw/handle/123456789/516782
標題: | Response | 作者: | FANG-JU LIN Chang, Ting-Yu JUNG-YIEN CHIEN |
公開日期: | 六月-2020 | 出版社: | ELSEVIER | 卷: | 157 | 期: | 6 | 起(迄)頁: | 1684 | 來源出版物: | Chest | URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/516782 | ISSN: | 00123692 | DOI: | 10.1016/j.chest.2020.02.055 | SDG/關鍵字: | beta 2 adrenergic receptor stimulating agent; corticosteroid; fluticasone propionate plus salmeterol; corticosteroid; chronic obstructive lung disease; disease exacerbation; disease severity; drug efficacy; drug safety; drug use; eosinophil count; human; Letter; medical decision making; outcome assessment; pneumonia; priority journal; risk factor; scoring system; treatment outcome; chronic obstructive lung disease; Adrenal Cortex Hormones; Humans; Pulmonary Disease, Chronic Obstructive |
顯示於: | 臨床藥學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。